Home Healthcare Pharmaceuticals CNS Therapeutics Market

CNS Therapeutics Market Size, Share & Trends Analysis Report By Disease (Neurovascular Diseases, CNS Trauma, Mental Health, Neurodegenerative Diseases, Infectious Diseases) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR4719DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. CNS Therapeutics Market, By Disease 2022-2034 (USD MILLION/ Units)
    1. Neurovascular Diseases
    2. CNS Trauma
    3. Mental Health
    4. Neurodegenerative Diseases
    5. Infectious Diseases
  2. Regional CNS Therapeutics Market
    1. North America
      1. North America CNS Therapeutics Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      2. U.S.
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      3. Canada
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
    2. Europe
      1. Europe CNS Therapeutics Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      2. U.K.
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      3. Germany
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      4. France
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      5. Spain
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      6. Italy
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      7. Russia
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      8. Nordic
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      9. Benelux
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      10. Rest of Europe
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
    3. APAC
      1. APAC CNS Therapeutics Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      2. China
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      3. Korea
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      4. Japan
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      5. India
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      6. Australia
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      7. Singapore
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      8. Taiwan
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      9. South East Asia
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      10. Rest of Asia-Pacific
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
    4. Middle East and Africa
      1. Middle East and Africa CNS Therapeutics Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      2. UAE
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      3. Turkey
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      4. Saudi Arabia
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      5. South Africa
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      6. Egypt
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      7. Nigeria
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      8. Rest of MEA
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
    5. LATAM
      1. LATAM CNS Therapeutics Market By Disease 2022-2034 (USD MILLION/ Units)
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      2. Brazil
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      3. Mexico
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      4. Argentina
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      5. Chile
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      6. Colombia
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
      7. Rest of LATAM
        1. Neurovascular Diseases
        2. CNS Trauma
        3. Mental Health
        4. Neurodegenerative Diseases
        5. Infectious Diseases
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.